Kolon Ends One Asian Invossa Contract, But Hopes To Keep Others

 
• By Jung Won Shin

Korean firm Kolon terminates one Asia supply contract for Invossa, but appears hopeful it can maintain other remaining deals as it counts on resuming US clinical trials with the troubled gene therapy.

Domino
Kolon Doesn't Expect Domino Effect From Supply Deal Termination • Source: Shutterstock

More from South Korea

More from Focus On Asia